Insulet Corporation, commonly known for its innovative Omnipod® Insulin Management System, is a leading player in the diabetes care industry. Headquartered in the United States, Insulet operates primarily in North America and Europe, focusing on developing advanced insulin delivery solutions. Founded in 2000, the company has achieved significant milestones, including the launch of its tubeless insulin pump, which revolutionised diabetes management for many patients. Insulet's core product, the Omnipod, stands out due to its unique design that offers a wireless, waterproof, and discreet insulin delivery system. This innovative approach has positioned Insulet as a market leader, recognised for enhancing the quality of life for individuals with diabetes. With a commitment to continuous improvement and patient-centric solutions, Insulet remains at the forefront of diabetes technology, driving advancements that empower users to manage their condition effectively.
How does Insulet's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Insulet's score of 39 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Insulet Corporation reported total greenhouse gas emissions of approximately 13,830,000 kg CO2e, comprising 1,383,000 kg CO2e from Scope 1 emissions and about 11,467,000 kg CO2e from Scope 2 emissions (market-based). This marks a significant increase in emissions compared to 2023, where total emissions were approximately 4,974,000 kg CO2e, with Scope 1 emissions at 1,316,000 kg CO2e and Scope 2 emissions at about 3,977,000 kg CO2e (market-based). Insulet has made notable strides in reducing its carbon footprint. In 2021, the company achieved a reduction of approximately 19% in Scope 1 emissions compared to 2020. Looking ahead, Insulet is committed to a net-zero transition, with plans to establish targets for greenhouse gas emissions reduction and increase the use of renewable energy in its operations by 2030. This commitment includes investments in renewable energy and the pursuit of Green Building Index (GBI) and Leadership in Energy and Environmental Design (LEED) certifications for its new manufacturing facility in Malaysia, aimed at minimising environmental impact. Insulet's emissions data is not cascaded from any parent organisation, and the company is actively developing a blueprint for achieving its net-zero goals by 2025. The focus on both Scope 1 and Scope 2 emissions highlights Insulet's comprehensive approach to addressing its climate impact.
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 1,709,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,761,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Insulet has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

